alexa Precision Cancer Medicine: Spatiotemporal Genomes Heterogeneity Opens New Therapeutic Horizons
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Global Congress on Tissue Engineering, Regenerative & Precision Medicine
December 1-2, 2016 | San Antonio, USA

Dimitris Roukos
Ioannina University, Greece
Posters & Accepted Abstracts: J Tissue Sci Eng
DOI: 10.4172/2157-7552.C1.031
Background: Metastasis is the cause of death for millions of cancer patients annually worldwide. Spatiotemporal identification of resistant sub clones using breakthrough technological genome systems and methods can predict and prevent therapeutic resistance and metastatic relapse before it clinically occurs on the basis of genotype-phenotype map. Architecture of genome and nonlinear transcription: Clinical studies coupled with mathematical and experimental models, indicate that in some patients pre-existed large structural genome changes [copy number alterations (CNAs), chromosomal rearrangements] predict metastasis and death. But in most patients dynamic emergence of somatic mutations leading to intratumor heterogeneity results in metastasis as a late event or development of secondary resistance and metastatic relapse. Based on the dynamics of genomic clone’s evolution following Darwinian’s principles, innovative methods and next-generation sequencing (NGS) systems have been developed. Moreover, in the post-ENCODE era breakthrough approaches are being developed for understanding and disrupting transcriptional deregulated bio circuits with future nonlinear drugs. This lecture presents how using primary tumor multiregional NGS analysis, single-cell genome-NGS, circulating genomes sequencing as well as CRISPR-Cas system we could understand non coding genome functionality and comprehensive interpatient heterogeneity (IPH). This spatiotemporal IPH can not only predict therapeutic resistance and metastasis but also shape the discovery of novel both linear and nonlinear transcription drugs.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version